Skip to main content
Atrás
RDNT logo

RadNet, Inc.

Calidad de datos: 100%
RDNT
NASDAQ Healthcare Medical - Diagnostics & Research
$60.66
▲ $0.79 (1.32%)
Cap. Mercado: 4.71B
Rango del Día
$59.98 $61.87
Rango de 52 Semanas
$45.00 $85.84
Volumen
579,981
Promedio 50D / 200D
$69.11 / $69.40
Cierre Anterior
$59.87

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (631 pares)

Métrica Acción Mediana del Sector
P/E -252.4 0.2
P/B 4.3 3.0
ROE % -1.9 3.6
Net Margin % -0.9 3.8
Rev Growth 5Y % 11.6 9.9
D/E 1.7 0.2

Precio Objetivo de Analistas

Hold
$92.00 +51.7%
Low: $90.00 High: $95.00
P/E Futuro
96.03
EPS Futuro
$0.63
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
2.46B

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2028 $1.18
$1.13 – $1.23
 3.03B 2
FY2027 $1.01
$0.80 – $1.22
 2.72B 3
FY2026 $0.63
$0.39 – $0.85
 2.46B 3

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-03-02 $0.20 $0.23 +12.6%
2025-11-09 $0.22 $0.20 -10.3%
2025-08-10 $0.17 $0.31 +82.4%
2025-05-11 -$0.17 -$0.35 -105.9%
2025-02-27 $0.21 $0.22 +4.8%
2024-11-10 $0.14 $0.18 +32.5%
2024-08-07 $0.16 $0.16 0.0%
2024-05-08 -$0.09 $0.07 +177.8%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Puntos Clave

Revenue grew 11.60% annually over 5 years — strong growth
Earnings declined -767.81% over the past year
Generating 85.57M in free cash flow
PEG of 0.38 suggests growth is underpriced
ROIC of 2.31% — low return on invested capital
Interest coverage of 1.30× — tight debt servicing

Crecimiento

Revenue Growth (5Y)
11.60%
Revenue (1Y)11.51%
Earnings (1Y)-767.81%
FCF Growth (3Y)39.04%

Calidad

Return on Equity
-1.87%
ROIC2.31%
Net Margin-0.91%
Op. Margin4.45%

Seguridad

Debt / Equity
1.71
Current Ratio1.76
Interest Coverage1.30

Valoración

P/E Ratio
-252.41
Forward P/E96.03
P/B Ratio4.32
EV/EBITDA63.87
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 11.51% Revenue Growth (3Y) 12.34%
Earnings Growth (1Y) -767.81% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 11.60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.04B Net Income (TTM) -18.65M
ROE -1.87% ROA -0.50%
Gross Margin 4.45% Operating Margin 4.45%
Net Margin -0.91% Free Cash Flow (TTM) 85.57M
ROIC 2.31% FCF Growth (3Y) 39.04%
Safety
Debt / Equity 1.71 Current Ratio 1.76
Interest Coverage 1.30
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -252.41 Forward P/E 96.03
P/B Ratio 4.32 P/S Ratio 2.31
PEG Ratio 0.38 Forward PEG N/A
EV/EBITDA 63.87 Fwd EV/EBITDA 13.89
Forward P/S 1.92 Fwd Earnings Yield 1.04%
FCF Yield 1.82%
Market Cap 4.71B Enterprise Value 5.80B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.04B 1.83B 1.62B 1.43B 1.32B
Net Income -18.65M 2.79M 3.04M 10.65M 24.73M
EPS (Diluted) -0.25 0.04 0.05 0.17 0.46
Gross Profit 90.80M 249.12M 221.39M 165.72M 191.80M
Operating Income 90.80M 104.62M 98.70M 46.36M 82.55M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.76B 3.29B 2.69B 2.43B 2.06B
Total Liabilities 2.40B 2.15B 1.88B 1.94B 1.71B
Shareholders' Equity 1.09B 902.31M 630.70M 333.00M 228.90M
Total Debt 1.86B 1.73B 1.49B 1.51B 1.40B
Cash & Equivalents 767.22M 740.02M 342.57M 127.83M 134.61M
Current Assets 1.03B 1.02B 579.28M 367.18M 324.26M
Current Liabilities 586.76M 479.71M 437.45M 466.72M 374.78M